MedTrace

MedTrace has developed a system that enables hospitals to produce and administer 15O-water on site. 15O-water is used as a tracer substance in PET scanners. MedTrace's system includes proprietary imaging software that provides very clear images of the heart and allows doctors to diagnose coronary artery disease.
Medtrace color logo- Verve Ventures portfolio
Founders / Management Martin Stenfeldt, Rune Wiik Kristensen
Sectors Health & Bio, MedTech
Located in Lyngby - Denmark
Co-Investors Swisscanto Invest, Syddansk Innovation
Follow On

LinkedIn

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.